MYH9 and gastric cancer: Moreover, some studies showed that MYH9 was upregulated in gastric cancer, which could promote the transcription of β-catenin (55) and could be upregulated in esophageal squamous cell carcinoma (ESCC) facilitating cell metastasis (56).